AmeriCann, Inc. (ACAN)

$0.303

+0.00 (+0.66%)
Rating:
Recommendation:
-
Symbol ACAN
Price $0.303
Beta 1.109
Volume Avg. 0.01M
Market Cap 7.636M
Shares () -
52 Week Range 0.28-0.888
1y Target Est -
DCF Unlevered ACAN DCF ->
DCF Levered ACAN LDCF ->
ROE 4.16% Neutral
ROA 1.50% Neutral
Operating Margin -
Debt / Equity 170.94% Buy
P/E -
P/B 1.31 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Timothy Ryan Keogh
Real Estate
Real Estate Services
Other OTC

AmeriCann, Inc. operates as a specialized cannabis company in the United States. It designs, develops, leases, and operates cultivation, processing, and manufacturing facilities for licensed cannabis businesses. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is based in Denver, Colorado.